While both men and women can develop osteoporosis (OP), the chances of women developing OP are greater. The risk of OP increases further after a woman has reached menopause, which confers a four times higher risk of developing OP. In this module, we will take a look at the aetiology, prevalence, disease burden and diagnostic methods of postmenopausal OP (PMO), as well as explore the most commonly prescribed medication used in the prevention and treatment of PMO – bisphosphonates. CPD Reviewer: Dr Hew Fen Lee Consultant Endocrinologist Subang Jaya Medical Centre Selangor, Malaysia
Dr Hew Fen Lee
Subang Jaya Medical Centre Selangor, Malaysia
Please read thoroughly & understand the module before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.
The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards compliant browser
may be required to view the modules.